Pharmaceutical Technology

DECEMBER 5, 2023

Pacmilimab is under clinical development by CytomX Therapeutics and currently in Phase II for Skin Cancer.

40

40

Pharmaceutical Technology

DECEMBER 5, 2023

Pacmilimab is under clinical development by CytomX Therapeutics and currently in Phase II for Skin Cancer.

40

40

European Pharmaceutical Review

SEPTEMBER 26, 2022

At the 2022 European Society for Medical Oncology Congress (ESMO) conference, promising results from a Phase I trial, suggesting that a novel genetically modified (GM) herpes virus eradicated or reduced advanced cancers, were presented. After taking part in the trial, their cancers shrunk.

Side effects 93

Side effects Patients Consulting Medical 93

Medgadget

MAY 12, 2023

Researchers at the University of California San Diego have developed a wearable ultrasound patch that is intended to provide information on the stiffness of underlying tissues as deep as 4 cm below the surface of the skin. The process is inconvenient and provides only one snapshot in time of a clinical situation for each scan.

Medical 100

Medical Healthcare Healthcare Engineering 100

pharmaphorum

DECEMBER 14, 2022

The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna. The vaccine primes the immune system to attack the tumour cells, while Keytruda blocks an immunological ‘brake’ that protects the cancer.

Patients 97

Patients 97

European Pharmaceutical Review

AUGUST 10, 2023

Talquetamab as a first-in-class therapy is a new option for patients with this difficult-to-treat blood cancer ,” stated Dr Ajai Chari, Director of Multiple Myeloma Program, Professor of Clinical Medicine at the University of California, US.

Food and Drug Administration 98

Food and Drug Administration Food Pharmaceutical Patients 98

PM360

NOVEMBER 21, 2022

Recently, clinics and psychiatrists have been receptive to FDA approved Spravato , or esketamine, which is chemically related to ketamine and administered in clinics for treatment-resistant depression. Medable Simplifies Consent Management for Clinical Trials. Medable Simplifies Consent Management for Clinical Trials.

Government 52

Government Prescription FDA Patients 52

Pharmaceutical Technology

MARCH 17, 2023

The latest approval represents the sixth for the combination therapy, which is also indicated across several BRAF V600 solid tumours, including lung cancer, melanoma, and thyroid cancer. The regulatory approval is based on the data obtained from the Phase II/III TADPOLE trial.

Food and Drug Administration 52

Food and Drug Administration FDA Food Patients 52

European Pharmaceutical Review

NOVEMBER 3, 2022

In total there are some 524 microbiome therapeutics – 48 percent in pre-clinical development and 42 percent in clinical development – with live biotherapeutics products dominating (177 therapeutics). For example, the design of clinical trials, the IP laws – how can you patent live microbial environments – and safety profiles.

Safety 84

Safety Patients Pharmaceutical Marketing 84

pharmaphorum

SEPTEMBER 30, 2022

Simcere has taken SIM0278 to the brink of clinical testing, and says the drug can be delivered by subcutaneous injection to activate regulatory T cells (Tregs) that have been shown to dampen down inflammatory responses in preclinical disease models.

Pharma 52

Pharma Leads Medical Patients 52

Medgadget

MARCH 2, 2023

Yona Keisari, and came up with an idea of diffusing atoms that emit alpha particles throughout a tumor, in essence increasing the effective range of alpha radiation and making it practical for clinical use. Results from initial clinical trials were quite impressive. The rest of the patients had partial responses.

Manufacturing 83

Manufacturing Leads Patients Medicine 83

pharmaphorum

AUGUST 2, 2022

The results of the IMscin001 study found that an injection of Tecentriq under the skin taking just a few minutes was non-inferior to a 30 to 60-minute infusion with the IV version in terms of pharmacokinetics – how the active ingredient behaves in the body after administration.

Marketing 97

Marketing Competition Patients FDA 97

European Pharmaceutical Review

FEBRUARY 26, 2024

Clinical data showed approximately 60 percent reductions in plasma NfL concentrations in patients given Qalsody compared to placebo. Treating NSCLC Tizveni (tislelizumab) received a positive opinion from the CHMP for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults.

Medicine 91

Medicine Patients Marketing Pharmaceutical 91

European Pharmaceutical Review

JULY 26, 2022

Opdualag (relatlimab/nivolumab), intended for the treatment of melanoma, a type of skin cancer, that has spread to other parts of the body and cannot be removed by surgery, received a positive opinion from the CHMP. Hybrid medicine Thalidomide Lipomed (thalidomide) received a positive opinion for the treatment of multiple myeloma.

Medicine 90

Medicine Marketing Patients Safety 90

Medgadget

MAY 10, 2023

The researchers hope that the device could assist patients with eating disorders or conditions such as cachexia, a wasting condition that can occur in cancer patients. The concept was inspired by the skin of the Australian thorny devil lizard, which contains tiny grooves that help to draw water towards the lizard’s mouth.

Patients 86

Patients Management 86

pharmaphorum

JANUARY 23, 2023

Much rarer, SLL is nearly the same form of cancer as CLL, but malignant cells are concentrated in the lymph nodes, rather than in the blood and bone marrow. Second primary malignancies, including non-skin carcinomas, developed in 13% of patients, while atrial fibrillation or flutter were reported in 3.7% of patients.

FDA 52

FDA Food and Drug Administration Food Patients 52

PM360

OCTOBER 13, 2023

HCPs therefore turn to resources not pharma-associated for identifying treatment options, drug-related information, and clinical trial updates. One HCP participant commented on pharma content: “They will often provide clinical trial information, and although I think the data’s correct, it’s presented in a way that is maybe skewed.

Healthcare 59

Healthcare Healthcare Doctors Pharma 59

Medgadget

AUGUST 10, 2022

X-trodes , a medtech startup based in Israel, created Smart Skin, a wireless monitoring and analytics technology that is suitable for at-home sleep monitoring. The Smart Skin can detect a wide array of sleep disorders, including sleep apnea, narcolepsy, bruxism, restless leg syndrome, and insomnia. How is this suboptimal?

Patients 104

Patients Specialization Management Medical 104

Pharmaceutical Technology

FEBRUARY 18, 2023

According to Globaldata, it is involved in 34 clinical trials, of which 20 were completed, 1 is ongoing, and 13 were terminated. The rNPV model is a more conservative valuation measure that accounts for the risk of a drug in clinical development failing to progress. It is a new molecular entity (NME).

Prescription 40

Prescription Engineering Pharmaceutical products Networking 40

pharmaphorum

JULY 28, 2022

That could propel the Regeneron-partnered drug into the top five biggest sellers, behind massive brands like AbbVie’s immunology blockbuster Humira (adalimumab), Merck & Co’s cancer immunotherapy Keytruda (pembrolizumab) and COVID-19 vaccines.

Sales 59

Sales FDA Medicine Leads 59

PM360

SEPTEMBER 7, 2023

Then onto Tuan Vu, MD, Professor of Neurology, Director, Neuromuscular Division, EMG Laboratories, and ALS Clinic, Department of Neurology University of South Florida, who discussed the global clinical trial.

Patients 105

Patients Pharma Education Doctors 105

European Pharmaceutical Review

JANUARY 10, 2023

The research recognised 15 late-stage experimental treatments forecast to deliver annual sales of over $1 billion within five years, including a wide range of therapeutic developments for rare diseases and difficult-to-treat conditions, including HIV, Parkinson’s, and cancer. Several Phase III trials are now underway.   .

Food and Drug Administration 90

Food and Drug Administration FDA Food Medicine 90

Legacy MEDSearch

JULY 20, 2023

a leading clinical augmented reality med-tech company, announced today it received 510(k) clearance from the U.S. ” said Adam Cargill, Director of Quality, Regulatory and Clinical Affairs at MediView. ” said Adam Cargill, Director of Quality, Regulatory and Clinical Affairs at MediView. MediView XR, Inc.,

FDA 52

FDA Food and Drug Administration Recruitment Healthcare 52

PM360

SEPTEMBER 15, 2022

To bring in the patient perspective to explain how the clinical trial process could be improved. health literacy), share best practices, identify solutions, and execute actions to collectively address problems that create barriers for cancer patients across the U.S. To incorporate the patient voice in marketing efforts.

Patients 98

Patients Healthcare Healthcare Marketing 98

pharmaphorum

JANUARY 10, 2023

New drugs for immunological and inflammatory diseases feature prominently among new product launches this year that could top $1 billion in annual sales by 2027 or be clinical “game changers,” according to Clarivate.

FDA 52

FDA Marketing Pharma Sales 52

European Pharmaceutical Review

DECEMBER 22, 2022

mRNA technologies have emerged as an innovative and effective approach to developing new drugs that can potentially transform existing therapies or target difficult‑to‑treat indications including respiratory, cardiac, metabolic and autoimmune diseases, as well as cancer. Benefits of mRNA-based technology. New frontiers bring new challenges.

Medicine 107

Medicine Food and Drug Administration Transportation Distribution 107

Evolve Your Success

JUNE 13, 2023

Kelly currently thrives in diagnostic testing sales, specifically in a department that deals with skin cancer prognosis. I work on the skin side. We’re looking at skin cancer like melanoma and squamous cell carcinoma. We provide a service for cancer patients. G ive us a little insight on there.

Sales 52

Sales Medical sales Medical Doctors 52

MedCity News

DECEMBER 5, 2023

But Replimune’s therapy, an oncolytic virus, has better data in melanoma, and the company plans a 2024 FDA submission in this skin cancer. Replimune’s lead therapeutic candidate did not meet the two main goals of a study intended to support an FDA submission in cutaneous squamous cell carcinoma.

Leads 114

Leads FDA Biopharma Pharma 114

Pharmaceutical Technology

JULY 22, 2022

Muge Cevik, a clinical scientist, shared an article around the mystery of viral hepatitis cases in children. The phase 1 clinical trial will evaluate the safety and immune response of the vaccine in healthy individuals at the Kaiser Permanente Washington Health Research Institute in Seattle, the article detailed. Likes: 521.

Pharmaceutical 52

Pharmaceutical Medicine Safety 52

Celeritas

NOVEMBER 21, 2022

Findings show that AuNPs have been pivotal in the reduction of systemic drug toxicity and have lowered the development of resistance to cancer drugs [8]. The unique electromagnetic properties of carbon nanotubes (CNTs) have made them highly valuable in the transport of oligonucleotides into living Hela (immortal cervical cancer) cells.

Engineering 52

Engineering Transportation Side effects Networking 52

European Pharmaceutical Review

FEBRUARY 14, 2023

Recently there have been several key advances in the clinical development of messenger RNA (mRNA) vaccines, including vaccines for RSV and a personalised cancer vaccine. The findings are exciting and open the door for further clinical trials in melanoma, as well as other types of cancer.”

Food and Drug Administration 93

Food and Drug Administration Medicine Safety Consulting 93

European Pharmaceutical Review

NOVEMBER 24, 2022

s Libtayo ® (cemiplimab) for adults with recurrent or metastatic cervical cancer and disease progression while on or after platinum-based chemotherapy. Clinical trial for metastatic cervical cancer. Libtayo ® clinical trial safety data. percent), immune-mediated colitis (two percent) and immune-mediated skin ARs (1.9

Safety 89

Safety Patients Medicine Pharmaceutical 89

pharmaphorum

AUGUST 24, 2022

Diversity in clinical trials is a “scientific imperative”, but how can industry bridge the gap between “why” and “how”? Removing barriers to clinical trial participation for underserved groups is an essential part of addressing health inequalities. Clinical trial participation, she went on, was vital. Why, not how.

FDA 92

FDA Patients Recruitment Medical 92

Pharmaceutical Technology

NOVEMBER 23, 2022

The European Commission (EC) has granted approval for Regeneron Pharmaceuticals ’ immunotherapy,Libtayo (cemiplimab), as a single agent to treat recurrent or metastatic cervical cancer in adults. It attaches to PD-1 to hinder cancer cells from utilising the PD-1 pathway for suppressing the activation of T-cells.

Food and Drug Administration 52

Food and Drug Administration Food Safety Pharmaceutical 52

European Pharmaceutical Review

DECEMBER 18, 2023

Dr Maher elaborated on data from a clinical trial of GD2-specific CAR T-cells in children with relapsed refractory neuroblastoma. fold increase in the patients with lymphoma who were alive at two years post-study and did not experience cancer progression or require further cancer treatment compared to standard of care (SOC).

Manufacturing 97

Manufacturing Food and Drug Administration Medicine Pharmaceutical manufacturing 97

Evolve Your Success

MAY 9, 2023

Clinically, I tend to fall on the side of clinical roles where I try to get more surgeon buy-in and end-user buy-in, but we always deal with hospital administration. I go after the clinical value and I have somewhat found myself in more male-dominated roles. You have to have thick skin. 15+ years of clinical experience.

Medical 52

Medical Sales Medical sales Retail 52

Pharmaceutical Technology

FEBRUARY 26, 2023

EDP-1815 is under clinical development by Evelo Biosciences and currently in Phase II for Plaque Psoriasis (Psoriasis Vulgaris). Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. The company’s Evelo is a trademark of Evelo Biosciences.

Pharmaceutical 40

Pharmaceutical 40